157 related articles for article (PubMed ID: 28179333)
41. Intrahepatic portal hypertension due to sinusoidal metastasis from urothelial carcinoma.
Elosua González A; Rullan Iriarte M; Úriz Otano JI
Med Clin (Barc); 2017 Sep; 149(5):232-233. PubMed ID: 28473219
[No Abstract] [Full Text] [Related]
42. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
Junca A; Frouin E; Irani J; Fromont G; Levillain P
Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
[TBL] [Abstract][Full Text] [Related]
43. Yolk sac tumor differentiation in urothelial carcinoma of the urinary bladder: a case report and differential diagnosis.
Espejo-Herrera N; Condom-Mundó E
Diagn Pathol; 2020 Jun; 15(1):68. PubMed ID: 32493368
[TBL] [Abstract][Full Text] [Related]
44. Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary bladder: a case report.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):379-83. PubMed ID: 19766408
[TBL] [Abstract][Full Text] [Related]
45. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
46. Paget phenomenon of the vulva with histopathological features of high-grade urothelial carcinoma (transitional cell carcinoma).
Kurashige Y; Minemura T; Nagatani T
Eur J Dermatol; 2013; 23(4):556-7. PubMed ID: 23985168
[No Abstract] [Full Text] [Related]
47. High-grade urothelial carcinoma with squamous differentiation metastasizing to the tongue.
Khurram SA; Farthing PM; Whitworth A; McKechnie AJ; Fernando M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):e111-5. PubMed ID: 26525101
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M
Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067
[TBL] [Abstract][Full Text] [Related]
49. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.
Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A
Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719
[TBL] [Abstract][Full Text] [Related]
50. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
51. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
Faraj SF; Chaux A; Gonzalez-Roibon N; Munari E; Ellis C; Driscoll T; Schoenberg MP; Bivalacqua TJ; Shih IeM; Netto GJ
Hum Pathol; 2014 Nov; 45(11):2233-9. PubMed ID: 25175170
[TBL] [Abstract][Full Text] [Related]
52. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
[TBL] [Abstract][Full Text] [Related]
53. [Unusual variety of bladder urothelial carcinoma: "nest type" microlobular carcinoma: report of an anatomoclinical case and review of the literature].
Rioux-Leclercq N; Staerman F; Patard JJ; Billerey C; Guillé F; Lobel B; Ramée MP
Ann Urol (Paris); 2000 Feb; 34(1):9-12. PubMed ID: 10763418
[TBL] [Abstract][Full Text] [Related]
54. Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
Sledge DG; Patrick DJ; Fitzgerald SD; Xie Y; Kiupel M
Vet Pathol; 2015 Jan; 52(1):74-82. PubMed ID: 24608632
[TBL] [Abstract][Full Text] [Related]
55. p63 expression in ovarian tumours: immunopositivity in metastatic transitional cell carcinoma of the ovary.
Kalebi A; Hale M
Histopathology; 2008 Aug; 53(2):228. PubMed ID: 18518899
[No Abstract] [Full Text] [Related]
56. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
58. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
[TBL] [Abstract][Full Text] [Related]
60. Subcutaneous metastases after coelioscopic lymphadenectomy for vesical urothelial carcinoma.
Stolla V; Rossi D; Bladou F; Rattier C; Ayuso D; Serment G
Eur Urol; 1994; 26(4):342-3. PubMed ID: 7713135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
